GETI.B

210

+0.43%↑

CAMX

609

-0.41%↓

BIOAB

320.2

-0.12%↓

EKTA.B

55.45

-0.72%↓

VITR

138

-0.5%↓

GETI.B

210

+0.43%↑

CAMX

609

-0.41%↓

BIOAB

320.2

-0.12%↓

EKTA.B

55.45

-0.72%↓

VITR

138

-0.5%↓

GETI.B

210

+0.43%↑

CAMX

609

-0.41%↓

BIOAB

320.2

-0.12%↓

EKTA.B

55.45

-0.72%↓

VITR

138

-0.5%↓

GETI.B

210

+0.43%↑

CAMX

609

-0.41%↓

BIOAB

320.2

-0.12%↓

EKTA.B

55.45

-0.72%↓

VITR

138

-0.5%↓

GETI.B

210

+0.43%↑

CAMX

609

-0.41%↓

BIOAB

320.2

-0.12%↓

EKTA.B

55.45

-0.72%↓

VITR

138

-0.5%↓

Home・Список акций・RaySearch Laboratories AB

R
RaySearch Laboratories AB

Закрыт

228.5 -1.08

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

228

Макс.

229

Ключевые показатели
By Trading Economics
Доход	49M 89M
Продажи	27M 332M
P/E Средняя по отрасли	35.156 77.671
Прибыль на акцию	2.09
Дивидендная доходность	1.34
Рентабельность продаж	26.633
Сотрудники	450
EBITDA	53M 89M

Дивиденды
By Dow Jones
Дивидендная доходность Средняя по отрасли	1.34% 2.35%

Рыночная статистика
By TradingEconomics
Рыночная капитализация	84M 7.7B
Предыдущая цена открытия	229.58
Предыдущая цена закрытия	228.5

RaySearch Laboratories AB График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

14 дек. 2025 г., 22:53 UTC

Приобретения, слияния, поглощения

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

13 дек. 2025 г., 00:04 UTC

Приобретения, слияния, поглощения

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

14 дек. 2025 г., 23:46 UTC

Обсуждения рынка

Gold Edges Higher Amid Some Tailwinds -- Market Talk

14 дек. 2025 г., 23:36 UTC

Обсуждения рынка

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

14 дек. 2025 г., 22:38 UTC

Приобретения, слияния, поглощения

Fortescue to Take Full Control of US$101M Copper Miner Alta

14 дек. 2025 г., 22:02 UTC

Приобретения, слияния, поглощения

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

14 дек. 2025 г., 22:01 UTC

Приобретения, слияния, поглощения

Fortescue: Alta Owns the Canariaco Project in Northern Peru

14 дек. 2025 г., 22:01 UTC

Приобретения, слияния, поглощения

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

14 дек. 2025 г., 22:00 UTC

Приобретения, слияния, поглощения

Fortescue: Agreement Implies Total Equity Value of C$139 Million

14 дек. 2025 г., 22:00 UTC

Приобретения, слияния, поглощения

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

14 дек. 2025 г., 21:59 UTC

Приобретения, слияния, поглощения

Fortescue to Acquire Remaining 64% of Alta Copper

14 дек. 2025 г., 17:00 UTC

Отчет

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

14 дек. 2025 г., 08:30 UTC

Приобретения, слияния, поглощения

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

13 дек. 2025 г., 16:48 UTC

Приобретения, слияния, поглощения

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 дек. 2025 г., 08:00 UTC

Приобретения, слияния, поглощения

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 дек. 2025 г., 07:00 UTC

Приобретения, слияния, поглощения

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13 дек. 2025 г., 00:24 UTC

Приобретения, слияния, поглощения

Want a Piece Of SpaceX? -- Barrons.com

12 дек. 2025 г., 23:49 UTC

Приобретения, слияния, поглощения

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 дек. 2025 г., 22:52 UTC

Обсуждения рынка

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 дек. 2025 г., 22:32 UTC

Отчет

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 дек. 2025 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

12 дек. 2025 г., 20:45 UTC

Отчет

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 дек. 2025 г., 20:41 UTC

Обсуждения рынка

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 дек. 2025 г., 20:20 UTC

Обсуждения рынка

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 дек. 2025 г., 19:23 UTC

Отчет

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 дек. 2025 г., 18:35 UTC

Приобретения, слияния, поглощения

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 дек. 2025 г., 18:33 UTC

Приобретения, слияния, поглощения

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 дек. 2025 г., 18:31 UTC

Обсуждения рынка

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 дек. 2025 г., 17:49 UTC

Отчет

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 дек. 2025 г., 17:34 UTC

Приобретения, слияния, поглощения

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Сравнение c конкурентами

Изменение цены

RaySearch Laboratories AB Прогноз

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) is headquartered in Stockholm, Sweden.